108 related articles for article (PubMed ID: 3079037)
1. Cyclosporine nephrotoxicity has no influence on cellular infiltration in cadaveric renal allografts.
Wood RF; McWhinnie DL; Cranston D; Azevedo LS; Allen R; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1789. PubMed ID: 3079037
[No Abstract] [Full Text] [Related]
2. The impact of transplant aspiration cytology on management of cyclosporine A-treated renal transplant recipients.
Yussim A; Shapira Z; Shmueli D; Heilbronn YD; Kaufman L; Servadio C
Transplant Proc; 1987 Feb; 19(1 Pt 2):1658-9. PubMed ID: 3274399
[No Abstract] [Full Text] [Related]
3. The components of the leucocyte infiltration of human renal allografts are not equally sampled by fine needle aspiration and needle core biopsy.
Hughes DA; McWhinnie DL; Jones RM; Carter NP; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1652. PubMed ID: 3274395
[No Abstract] [Full Text] [Related]
4. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology.
Williamson EP; Millar RJ; Criddle RA; Sells RA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1785-6. PubMed ID: 3274423
[No Abstract] [Full Text] [Related]
5. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity.
Post GR; Moyer TP; Anderson CF; Sterioff S
Transplant Proc; 1987 Feb; 19(1 Pt 2):1761-3. PubMed ID: 3079036
[No Abstract] [Full Text] [Related]
6. Evaluation of cyclosporine-induced nephrotoxicity by immunoperoxidase analysis of renal allograft biopsies.
Kolbeck PC; Wolfe JA; Burchette J; Sanfilippo F
Transplant Proc; 1987 Feb; 19(1 Pt 2):1781-4. PubMed ID: 3547883
[No Abstract] [Full Text] [Related]
7. Primary dysfunction of renal allografts as a risk factor.
Margreiter R; Bösmüller C; Spielberger M; Königsrainer A; Dünser M
Transplant Proc; 1990 Aug; 22(4):1373-4. PubMed ID: 2389333
[No Abstract] [Full Text] [Related]
8. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
[No Abstract] [Full Text] [Related]
9. Cyclosporine-induced nephrotoxicity: role of prostaglandins.
Jorkasky D; Audet P; Williams S; Grossman R; Conrad M
Transplant Proc; 1987 Feb; 19(1 Pt 2):1742-4. PubMed ID: 3079035
[No Abstract] [Full Text] [Related]
10. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
[No Abstract] [Full Text] [Related]
11. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
[No Abstract] [Full Text] [Related]
12. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients.
Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M
Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405
[No Abstract] [Full Text] [Related]
13. Morphologic and phenotypic analysis of cellular infiltration in renal allograft biopsies after long-term cyclosporine A therapy.
Versluis DJ; Ten Kate FJ; Vaessen LM; Jeekel J; Weimar W
Transplant Proc; 1988 Jun; 20(3 Suppl 3):800-6. PubMed ID: 3291317
[No Abstract] [Full Text] [Related]
14. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
[No Abstract] [Full Text] [Related]
15. Baseline biopsies define cyclosporine nephrotoxicity.
Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
[No Abstract] [Full Text] [Related]
16. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity.
Dawidson I; Rooth P; Alway C; Dulzo T; Palmer B; Lu C; Peters P; Sagalowsky A; Sandor Z
Transplant Proc; 1990 Aug; 22(4):1379-80. PubMed ID: 2202113
[No Abstract] [Full Text] [Related]
17. Glycosuria: an index of cyclosporine nephrotoxicity.
Chan P; Chapman JR; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1780. PubMed ID: 3274422
[No Abstract] [Full Text] [Related]
18. Verapamil ameliorates acute cyclosporine A (CsA) nephrotoxicity and improves immunosuppression after cadaver renal transplantation.
Dawidson I; Rooth P; Fisher D; Fry WR; Alway C; Coorpender L; Reisch J
Transplant Proc; 1989 Feb; 21(1 Pt 2):1511-3. PubMed ID: 2652487
[No Abstract] [Full Text] [Related]
19. Confirmation of the utility of the fine needle aspiration biopsy of the transplanted kidney.
Helderman JH; Hernandez J; Glennie J; Sagalowksy A; Toto R; Kokko JP
Transplant Proc; 1987 Feb; 19(1 Pt 2):1653-4. PubMed ID: 3274396
[No Abstract] [Full Text] [Related]
20. Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats.
Yagisawa T; Takahashi K; Teraoka S; Toma H; Agishi T; Ota K
Transplant Proc; 1987 Feb; 19(1 Pt 2):1801-3. PubMed ID: 3079039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
